This article describes recent findings from genetically engineered murine models of type 2 diabetes, particularly those giving insight into defects in insulin's actions and the relationship between insulin resistance and impaired β-cell function. These models have the potential to examine specific molecular mechanisms that combine to cause diabetes in humans.
- Derek LeRoith
- Domenico Accili
